Healthcare & Life Sciences
RareCyte
United Stateswww.rarecyte.com
RareCyte is a series c plus startup based in United States. 1 investor tracked.
Activeseries-c-plus
series-c-plus
Stage
2010
Founded
4
Investors
About RareCyte
RareCyte is a company founded in 2010 headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 4 investors associated with the company.
RareCyte develops high-plex spatial proteomics and liquid biopsy platforms that enable multiplex immunofluorescence and rare cell detection to support biomarker development and translational and clinical research at clinical scale.
Explore RareCyte's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.